Mark Exley

Company: Lift Biosciences

Job title: Chief Scientific Officer

Seminars:

Harnessing Engineered iPSC-Derived Immuno-Modulatory Alpha Neutrophils for Immune Reconstitution & Cancer Therapy 2:00 pm

Exploring the potential of iPSC-derived alpha neutrophils to restore immune function in oncology and age-related diseases Strategies to leverage these cells for robust immune reconstitution following immunosuppressive treatments Evaluating therapeutic applications across cancer and chronic inflammation driven by immune decline with ageRead more

day: Day One Track A Afternoon